Literature DB >> 24150570

Changes in neural circuitry regulating response-reversal learning and Arc-mediated consolidation of learning in rats with methamphetamine-induced partial monoamine loss.

Elissa D Pastuzyn1, Kristen A Keefe2.   

Abstract

Methamphetamine (METH)-induced neurotoxicity results in long-lasting depletions of monoamines and changes in basal ganglia function. We previously reported that rats with METH-induced neurotoxicity no longer engage dorsomedial striatum during a response-reversal learning task, as their performance is insensitive to acute disruption of dorsomedial striatal function by local infusion of an N-methyl-D-aspartate receptor antagonist or an antisense oligonucleotide against the activity-regulated cytoskeleton-associated (Arc) gene. However, METH-pretreated rats perform the task as well as controls. Therefore, we hypothesized that the neural circuitry involved in the learning had changed in METH-pretreated rats. To test this hypothesis, rats were pretreated with a neurotoxic regimen of METH or with saline. After 3-5 weeks, rats were trained on the reversal-learning task and in situ hybridization for Arc was performed. A significant correlation between Arc expression and performance on the task was found in nucleus accumbens shell of METH-, but not saline-, pretreated rats. Consistent with the idea that the correlation between Arc expression in a brain region and behavioral performance implicates that brain region in the learning, infusion of an antisense oligonucleotide against Arc into the shell impaired consolidation of reversal learning in METH-, but not saline-, pretreated rats. These findings provide novel evidence suggesting that METH-induced neurotoxicity leads to a shift from dorsal to ventral striatal involvement in the reversal-learning task. Such reorganization of neural circuitry underlying learning and memory processes may contribute to impaired cognitive function in individuals with METH-induced neurotoxicity or others with striatal dopamine loss, such as patients with Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24150570      PMCID: PMC3924530          DOI: 10.1038/npp.2013.296

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  47 in total

1.  Fear and feeding in the nucleus accumbens shell: rostrocaudal segregation of GABA-elicited defensive behavior versus eating behavior.

Authors:  S M Reynolds; K C Berridge
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

2.  Disruption of subcellular Arc/Arg 3.1 mRNA expression in striatal efferent neurons following partial monoamine loss induced by methamphetamine.

Authors:  Melissa L Barker-Haliski; Katharina Oldenburger; Kristen A Keefe
Journal:  J Neurochem       Date:  2012-10-10       Impact factor: 5.372

Review 3.  Methamphetamine influences on brain and behavior: unsafe at any speed?

Authors:  John F Marshall; Steven J O'Dell
Journal:  Trends Neurosci       Date:  2012-06-16       Impact factor: 13.837

4.  Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites.

Authors:  G L Lyford; K Yamagata; W E Kaufmann; C A Barnes; L K Sanders; N G Copeland; D J Gilbert; N A Jenkins; A A Lanahan; P F Worley
Journal:  Neuron       Date:  1995-02       Impact factor: 17.173

Review 5.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

Review 6.  Dopamine-mediated regulation of corticostriatal synaptic plasticity.

Authors:  Paolo Calabresi; Barbara Picconi; Alessandro Tozzi; Massimiliano Di Filippo
Journal:  Trends Neurosci       Date:  2007-03-23       Impact factor: 13.837

Review 7.  An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans.

Authors:  Andy C Dean; Stephanie M Groman; Angelica M Morales; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2012-09-05       Impact factor: 7.853

8.  High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain.

Authors:  J W Boja; W M Mitchell; A Patel; T A Kopajtic; F I Carroll; A H Lewin; P Abraham; M J Kuhar
Journal:  Synapse       Date:  1992-09       Impact factor: 2.562

9.  Methamphetamine-induced neurotoxicity disrupts naturally occurring phasic dopamine signaling.

Authors:  Christopher D Howard; David P Daberkow; Eric S Ramsson; Kristen A Keefe; Paul A Garris
Journal:  Eur J Neurosci       Date:  2013-04-11       Impact factor: 3.386

Review 10.  Behavioral dopamine signals.

Authors:  Wolfram Schultz
Journal:  Trends Neurosci       Date:  2007-04-02       Impact factor: 13.837

View more
  2 in total

1.  Activity-Dependent Arc Expression and Homeostatic Synaptic Plasticity Are Altered in Neurons from a Mouse Model of Angelman Syndrome.

Authors:  Elissa D Pastuzyn; Jason D Shepherd
Journal:  Front Mol Neurosci       Date:  2017-07-28       Impact factor: 5.639

Review 2.  Immediate Early Genes, Memory and Psychiatric Disorders: Focus on c-Fos, Egr1 and Arc.

Authors:  Francisco T Gallo; Cynthia Katche; Juan F Morici; Jorge H Medina; Noelia V Weisstaub
Journal:  Front Behav Neurosci       Date:  2018-04-25       Impact factor: 3.558

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.